Skip to main content
Premium Trial:

Request an Annual Quote

Arcis, Opentrons Sign Sample Prep Product Distribution Deal

NEW YORK — Arcis Biotechnology said today that it has signed a global distribution agreement for its nucleic acid sample prep products with Opentrons.

Under the terms of the deal, New York City-based Opentrons will offer Arcis' line of nucleic acid extraction and preservation products with its automated OT-2 lab robot platform to customers worldwide. Additional terms were not disclosed.

"Arcis' reagent-only solution is a compelling offering for biologists, but when you automate that protocol, it offers a high-throughput sample preparation workflow for every molecular biology laboratory," Opentrons Cofounder and Chief Product Officer Will Canine said in a statement.

Earlier this year, UK-based Arcis inked a comarketing deal for its sample prep reagents with Andrew Alliance. In late 2018, it signed an agreement giving Teleflex the right to use the chemistry to develop a diagnostic assay.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.